Immunogenicity and safety of an inactivated 2012/2013 trivalent influenza vaccine produced in mammalian cell culture (Optaflu(®)): An open label, uncontrolled study

por Vinnemeier, Christof David, Fischer-Herr, Johanna, Meyer, Seetha, Liebig, Katja, Theeß, Wiebke, Burchard, Gerd-Dieter, Cramer, Jakob P
Publicado 2014

Clinical Trial to Evaluate the Safety and Immunogenicity of a Trivalent Surface Antigen Seasonal Influenza Vaccine Produced in Mammalian Cell Culture and Administered to Young and...

por Loebermann, Micha, Voss, Ulrich, Meyer, Seetha, Bosse, Dietrich, Fritzsche, Carlos, Klammt, Sebastian, Frimmel, Silvius, Riebold, Diana, Reisinger, Emil C.
Publicado 2013

A 2013/2014 northern hemisphere season surface antigen inactivated trivalent influenza vaccine - Assessing the immunogenicity and safety in an open label, uncontrolled study

por Roggelin, Louise, Vinnemeier, Christof D, Meyer, Seetha, Witte, Kai, Marx, Lydia, Theeß, Wiebke, Burchard, Gerd D, Rolling, Thierry, Cramer, Jakob P
Publicado en Hum Vaccin Immunother (2015)